2/24
02:04 am
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
2/19
08:40 am
cort
Corcept Therapeutics: Key Catalysts Ahead [Seeking Alpha]
Low
Report
Corcept Therapeutics: Key Catalysts Ahead [Seeking Alpha]
2/17
08:40 am
cort
Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
2/16
10:03 pm
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
2/16
03:13 pm
cort
Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow [Yahoo! Finance]
Neutral
Report
Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow [Yahoo! Finance]
2/16
09:21 am
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $36.00 to $42.00. They now have a "buy" rating on the stock.
High
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $36.00 to $42.00. They now have a "buy" rating on the stock.
2/16
09:13 am
cort
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/15
04:55 pm
cort
Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ... [Yahoo! Finance]
Medium
Report
Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ... [Yahoo! Finance]
2/15
04:14 pm
cort
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial [Yahoo! Finance]
Medium
Report
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial [Yahoo! Finance]
2/15
04:14 pm
cort
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update [Yahoo! Finance]
2/15
04:07 pm
cort
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update
Medium
Report
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update
2/15
04:02 pm
cort
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
Medium
Report
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
2/14
02:51 am
cort
Jim Simons Bolsters Position in Corcept Therapeutics Inc [Yahoo! Finance]
Medium
Report
Jim Simons Bolsters Position in Corcept Therapeutics Inc [Yahoo! Finance]
2/8
04:24 pm
cort
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call [Yahoo! Finance]
Low
Report
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call [Yahoo! Finance]
2/8
04:05 pm
cort
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
Medium
Report
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
1/29
08:09 am
cort
Corcept Appoints Roberto Vieira as President, Oncology [Yahoo! Finance]
Medium
Report
Corcept Appoints Roberto Vieira as President, Oncology [Yahoo! Finance]
1/29
08:00 am
cort
Corcept Appoints Roberto Vieira as President, Oncology
Medium
Report
Corcept Appoints Roberto Vieira as President, Oncology
1/8
08:08 am
cort
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program [Yahoo! Finance]
Medium
Report
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program [Yahoo! Finance]
1/8
08:00 am
cort
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
Medium
Report
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
1/4
11:04 am
cort
Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains? [Yahoo! Finance]
1/2
02:13 pm
cort
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at HC Wainwright from $34.00 to $28.00. They now have a "buy" rating on the stock.
Neutral
Report
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at HC Wainwright from $34.00 to $28.00. They now have a "buy" rating on the stock.
1/2
12:53 pm
cort
Corcept Therapeutics Stock is Down 27%. It's an ‘Ideal Buying Opportunity.' [MarketWatch]
Low
Report
Corcept Therapeutics Stock is Down 27%. It's an ‘Ideal Buying Opportunity.' [MarketWatch]
1/2
09:31 am
cort
Thinking about trading options or stock in Exxon Mobil, Amazon.com, Meta Platforms, Enterprise Products Partners, or Corcept Therapeutics?
Medium
Report
Thinking about trading options or stock in Exxon Mobil, Amazon.com, Meta Platforms, Enterprise Products Partners, or Corcept Therapeutics?
1/2
08:00 am
cort
Court Finds Corcept Therapeutics’ Patents Not Infringed
Medium
Report
Court Finds Corcept Therapeutics’ Patents Not Infringed
1/2
06:57 am
cort
Wall Street Breakfast Podcast: Fewer EV Models Qualify For Full Tax Credit [Seeking Alpha]
Neutral
Report
Wall Street Breakfast Podcast: Fewer EV Models Qualify For Full Tax Credit [Seeking Alpha]